On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to gov.

Scientists have found a breakthrough in the search for a cure for HIV, after research uncovered a development “previously thought impossible”. HIV can ‘hide’ itself in white blood cells, meaning the ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

A new analysis finds that generic lenacapavir, a twice-yearly HIV preventive treatment, could be mass produced for just $25 ...

Dr Joel Steingo of TB HIV Care says Lenacapavir could be a breakthrough in reducing infections, especially at a time when ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

A drug with 96 to 100% efficacy in preventing HIV will be available to 120 countries, including South Africa, starting in 2027. This after two Indian drugmakers Dr Reddy’s and Hetero announced last ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Gilead Sciences (GILD) is drawing attention this week as it presents new clinical results at both the European AIDS ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...